Want to see XRN full AI Analyst Report?
XRN Stock Chart & Stats
$36.82
-$0.13(-1.62%)
At close: 4:00 PM EST
$36.82
-$0.13(-1.62%)
Day’s Range― - ―
52-Week Range$29.05 - $39.93
Previous CloseN/A
VolumeN/A
Average Volume (3M)92.86K
Market Cap
$533.69M
Enterprise Value$1.38K
Total Cash (Recent Filing)$10.66M
Total Debt (Recent Filing)$636.93M
Price to Earnings (P/E)9.4
Beta0.56
Next Earnings
Nov 10, 2026EPS Estimate
-0.5Next Dividend Ex-DateN/A
Dividend Yield5.38%
Share Statistics
EPS (TTM)3.72
Shares Outstanding13,237,830
10 Day Avg. Volume74,138
30 Day Avg. Volume92,855
Financial Highlights & Ratios
PEG Ratio0.10
Price to Book (P/B)0.92
Price to Sales (P/S)2.90
P/FCF Ratio-57.89
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$41.50Price Target Upside12.71% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering4
EPS Forecast (FY)1.31
Revenue Forecast (FY)$148.93M
Bulls Say, Bears Say
Bulls Say
Cash GenerationSustained positive operating cash flow and strong trailing free cash flow provide a durable funding source to cover distributions, redeploy capital from sales, and support the senior-housing pivot. Consistent cash conversion underpins capital allocation flexibility and reduces near-term refinancing pressure.
Liquidity & Leverage ImprovementSignificant unused credit capacity and measurable improvement in debt metrics give the company multi-quarter flexibility to execute asset sales and purchases. No debt maturities until 2028 and preferred issuance expand optionality, helping sustain a multi-month repositioning strategy without urgent refinancing.
Strategic Pivot To Seniors HousingA clear and resourced pivot toward senior housing, backed by a sizable $421M pipeline and experienced hires, targets higher unlevered returns and recurring operating cash flow. This structural repositioning, if executed, can raise portfolio quality and long-term ROIC versus legacy outpatient assets.
Bears Say
Revenue CollapseA near-total TTM revenue decline signals structural disruption to the top line that may not reverse quickly. Durable earnings and FFO depend on replacing lost outpatient revenues with stabilized seniors cash flow; prolonged revenue weakness strains predictability and growth planning.
Elevated LeverageAlthough improving, leverage remains elevated for a portfolio transition phase. High net-debt/EBITDAre limits strategic flexibility, raises refinancing and covenant risk if cash flows dip, and increases required execution precision on disposals and redeployments to avoid impairing returns or liquidity.
Cash-flow VolatilityHistoric swings in free cash flow highlight sensitivity to capex, asset sales, and working capital. This volatility undermines reliable dividend funding and makes multi-year planning riskier; durable investor confidence requires repeatable, predictable FCF from the new senior-housing mix.
Chiron Real Estate ate News
XRN FAQ
What was Chiron Real Estate ate’s price range in the past 12 months?
Chiron Real Estate ate lowest stock price was $29.05 and its highest was $39.93 in the past 12 months.
What is Chiron Real Estate ate’s market cap?
Chiron Real Estate ate’s market cap is $533.69M.
When is Chiron Real Estate ate’s upcoming earnings report date?
Chiron Real Estate ate’s upcoming earnings report date is Nov 10, 2026 which is in 71 days.
How were Chiron Real Estate ate’s earnings last quarter?
Chiron Real Estate ate released its earnings results on Aug 05, 2026. The company reported $4.78 earnings per share for the quarter, beating the consensus estimate of -$0.235 by $5.015.
Is Chiron Real Estate ate overvalued?
According to Wall Street analysts Chiron Real Estate ate’s price is currently Undervalued.
Does Chiron Real Estate ate pay dividends?
Chiron Real Estate ate pays a Quarterly dividend of $0.16 which represents an annual dividend yield of 5.38%. See more information on Chiron Real Estate ate dividends here
What is Chiron Real Estate ate’s EPS estimate?
Chiron Real Estate ate’s EPS estimate is -0.5.
How many shares outstanding does Chiron Real Estate ate have?
Chiron Real Estate ate has 13,237,830 shares outstanding.
What happened to Chiron Real Estate ate’s price movement after its last earnings report?
Chiron Real Estate ate reported an EPS of $4.78 in its last earnings report, beating expectations of -$0.235. Following the earnings report the stock price went up 1.143%.
Which hedge fund is a major shareholder of Chiron Real Estate ate?
Currently, no hedge funds are holding shares in XRN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Chiron Real Estate ate Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$41.50 (12.71% Upside)
$41.50 (12.71% Upside)
Blogger Sentiment
Bullish
XRN Sentiment 87%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 28.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $2.6M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.1%
Last 30 Days ▼ 7.9%
Last 30 Days ▼ 7.9%
Technicals
SMA
Positive
20 days / 200 days
Momentum
15.15%
12-Months-Change
Fundamentals
Return on Equity
5.38%
Trailing 12-Months
Asset Growth
5.77%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Chiron Real Estate ate
Chiron is a real estate investment trust focused on investing in and actively managing critical healthcare infrastructure. With more than a decade of experience as a public company, it has built a diversified portfolio anchored by strong tenants who deliver essential care in their communities nationwide.
XRN Company Deck
XRN Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed a constructive strategic pivot toward senior housing with concrete execution: leadership additions, sizable asset sales and acquisitions, equity issuance, improved liquidity and modest improvement in leverage. At the same time, operating growth is modest, net debt/EBITDAre remains elevated, short-term G&A will rise due to hiring, and there is uncertainty and timing risk around fully monetizing outpatient medical assets and achieving market revaluation. Overall, the company demonstrated meaningful progress and tactical wins but still faces execution and valuation headwinds during the transition.View all XRN earnings summariesXRN Stock 12 Month Forecast
Average Price Target
$41.50
▲(12.71% Upside)
Technical Analysis
Diversified Healthcare Trust
―
Community Healthcare
―
Universal Health Realty Income
―
Strawberry Fields REIT Inc
―
―
Ownership Overview
1.86% Insiders
24.80% Mutual Funds
26.51% Other Institutional Investors
28.53% Public Companies and
Individual Investors